Benzinga | Dec 17, 2021 01:40PM EST

Global Blood Therapeutics Gets FDA Approval Of Oxbryta For Treatment Of Sickle Cell Disease In Children Ages 4-11

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-sickle-cell-disease-patients-aged-4-11-years